Reuters Health Report: December 19, 2016

Click to View in Browser Monday, December 19, 2016 South Korea, Japan step up poultry cull to contain bird flu SEOUL (Reuters) - South Korea and Japan have ordered fresh culls of poultry stocks to contain outbreaks of avian flu, authorities in the two countries said. Poultry culled in Germany after bird flu found on two farms HAMBURG, Germany (Reuters) - About 30,000 turkeys and ducks were culled in Germany over the weekend after bird flu was found on two farms, authorities said on Monday. Richter withdraws marketing application for biosimilar drug BUDAPEST (Reuters) - Hungarian pharmaceuticals firm Richter has withdrawn its marketing application for one of its biosimilar drugs from the European Medicines Agency in anticipation of a possible negative assessment, the company said on Monday. Medigene eyeing more immunotherapy deals after Bluebird pact FRANKFURT (Reuters) - German biotech firm Medigene said it is drawing more interest from prospective alliance partners for its technology to boost the immune response to cancer after its deal with U.S. peer Bluebird Bio. Japan to review drug prices annually vs every two years previously: sources TOKYO (Reuters) - The Japanese government plans to start reviewing drug prices every year, instead of every two years, in a bid to reduce mounting healthcare costs, government officials with direct knowledge of the decision said on Monday. Malaysia confirms its eighth Zika virus case KUALA LUMPUR (Reuters) - Malaysia confirmed an eighth Zika virus case on Sunday, involving a 67-year-old man who first showed symptoms in late November. Heimlich, developer of maneuver to save choking victims, dead at 96 (Reuters) - Henry Heimlich, the medical maverick who came up with a maneuver credited with saving thousands of choking victims but who damaged his standing as a proponent of the curative powers of malaria, died on Saturday at the age of 96. Mylan launches EpiPen generic at $300 per two-pack (Reuters) - Mylan NV, which has come under fire for its drug pricing, said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment for $300 per two-pack, a more than 50 percent discount. Novartis says buys Ziarco Group to expand skin care portfolio ZURICH (Reuters) - Novartis is buying privately held drugmaker Ziarco Group for an undisclosed sum to gain access to its investigational eczema medicine, the Swiss pharmaceutical giant said on Friday. U.S. lawmakers press Heritage Pharma on high prices for antibiotic WASHINGTON (Reuters) - Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing. Related Video Beijing residents brace for smog alert NASA launches hurricane-tracking satellites A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2016 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook